Colgate Brushes Past Earnings Estimates. It Wasn't Enough. -- Barrons.com

Dow Jones

31 Jan

By Emily Dattilo

Shares of Colgate-Palmolive were falling after the consumer products company turned in higher earnings than expected but disappointed investors with its financial guidance.

The stock was down 5.5% to $85.93 in early trading.

For its fourth quarter, the company reported adjusted earnings of 91 cents per share, beating the consensus call for 89 cents among analysts tracked by FactSet. Net sales of $4.94 billion were below the consensus estimate of $4.98 billion.

"Our goals for 2024 were to deliver peer leading growth while funding investment for future growth and building flexibility into our P&L to counter macro headwinds," said CEO Noel Wallace in a statement. "We delivered on those goals, leaving us well positioned to deliver against our guidance in 2025."

For 2025, Colgate forecasts net sales to be roughly flat, while analysts had penciled in an increase of about 1%.

The company expects organic sales growth to be within the 3% to 5% range it has set as a long-term target, including the effects of a plan to leave the private-label pet nutrition business over the course of the year.

Write to Emily Dattilo at emily.dattilo@dowjones.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

January 31, 2025 09:53 ET (14:53 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2507966293"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2507966293\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2507966293?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-31 22:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2507966293","market":"other","top_or_hot":-1,"title":"Colgate Brushes Past Earnings Estimates. It Wasn't Enough. -- Barrons.com","media":"Dow Jones","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Emily Dattilo \n</p>\n<p>\n  Shares of Colgate-Palmolive were falling after the consumer products company turned in higher earnings than expected but disappointed investors with its financial guidance. \n</p>\n<p>\n     The stock was down 5.5% to $85.93 in early trading. \n</p>\n<p>\n     For its fourth quarter, the company reported adjusted earnings of 91 cents per share, beating the consensus call for 89 cents among analysts tracked by FactSet. Net sales of $4.94 billion were below the consensus estimate of $4.98 billion. \n</p>\n<p>\n     \"Our goals for 2024 were to deliver peer leading growth while funding investment for future growth and building flexibility into our P&L to counter macro headwinds,\" said CEO Noel Wallace in a statement. \"We delivered on those goals, leaving us well positioned to deliver against our guidance in 2025.\" \n</p>\n<p>\n     For 2025, Colgate forecasts net sales to be roughly flat, while analysts had penciled in an increase of about 1%. \n</p>\n<p>\n     The company expects organic sales growth to be within the 3% to 5% range it has set as a long-term target, including the effects of a plan to leave the private-label pet nutrition business over the course of the year. \n</p>\n<p>\n     Write to Emily Dattilo at emily.dattilo@dowjones.com \n</p>\n<p>\n     This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 31, 2025 09:53 ET (14:53 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones & Company, Inc.\n</p>\n</font></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Colgate Brushes Past Earnings Estimates. It Wasn't Enough. -- Barrons.com</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nColgate Brushes Past Earnings Estimates. It Wasn't Enough. -- Barrons.com\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-31 22:53</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Emily Dattilo \n</p>\n<p>\n  Shares of Colgate-Palmolive were falling after the consumer products company turned in higher earnings than expected but disappointed investors with its financial guidance. \n</p>\n<p>\n     The stock was down 5.5% to $85.93 in early trading. \n</p>\n<p>\n     For its fourth quarter, the company reported adjusted earnings of 91 cents per share, beating the consensus call for 89 cents among analysts tracked by FactSet. Net sales of $4.94 billion were below the consensus estimate of $4.98 billion. \n</p>\n<p>\n     \"Our goals for 2024 were to deliver peer leading growth while funding investment for future growth and building flexibility into our P&L to counter macro headwinds,\" said CEO Noel Wallace in a statement. \"We delivered on those goals, leaving us well positioned to deliver against our guidance in 2025.\" \n</p>\n<p>\n     For 2025, Colgate forecasts net sales to be roughly flat, while analysts had penciled in an increase of about 1%. \n</p>\n<p>\n     The company expects organic sales growth to be within the 3% to 5% range it has set as a long-term target, including the effects of a plan to leave the private-label pet nutrition business over the course of the year. \n</p>\n<p>\n     Write to Emily Dattilo at emily.dattilo@dowjones.com \n</p>\n<p>\n     This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 31, 2025 09:53 ET (14:53 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones & Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CL","symbol_name":"高露洁","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2507966293","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2507966293","pubTimestamp":1738335180,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Colgate-Palmolive were falling after the consumer products company turned in higher earnings than expected but disappointed investors with its financial guidance.The stock was down 5.5% to $85.93 in early trading.For its fourth quarter, the company reported adjusted earnings of 91 cents per share, beating the consensus call for 89 cents among analysts tracked by FactSet. Net sales of $4.94 billion were below the consensus estimate of $4.98 billion.\"Our goals for 2024 were to deliver peer leading growth while funding investment for future growth and building flexibility into our P&L to counter macro headwinds,\" said CEO Noel Wallace in a statement. \"We delivered on those goals, leaving us well positioned to deliver against our guidance in 2025.\". For 2025, Colgate forecasts net sales to be roughly flat, while analysts had penciled in an increase of about 1%.The company expects organic sales growth to be within the 3% to 5% range it has set as a long-term target, including the ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CL":"高露洁"},"translate_title":"高露洁超出盈利预期。这还不够。——Barrons.com","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CL":0.9},"content_text":"By Emily Dattilo \n\n\n  Shares of Colgate-Palmolive were falling after the consumer products company turned in higher earnings than expected but disappointed investors with its financial guidance. \n\n\n     The stock was down 5.5% to $85.93 in early trading. \n\n\n     For its fourth quarter, the company reported adjusted earnings of 91 cents per share, beating the consensus call for 89 cents among analysts tracked by FactSet. Net sales of $4.94 billion were below the consensus estimate of $4.98 billion. \n\n\n     \"Our goals for 2024 were to deliver peer leading growth while funding investment for future growth and building flexibility into our P&L to counter macro headwinds,\" said CEO Noel Wallace in a statement. \"We delivered on those goals, leaving us well positioned to deliver against our guidance in 2025.\" \n\n\n     For 2025, Colgate forecasts net sales to be roughly flat, while analysts had penciled in an increase of about 1%. \n\n\n     The company expects organic sales growth to be within the 3% to 5% range it has set as a long-term target, including the effects of a plan to leave the private-label pet nutrition business over the course of the year. \n\n\n     Write to Emily Dattilo at emily.dattilo@dowjones.com \n\n\n     This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 31, 2025 09:53 ET (14:53 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}